Kato et al., Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy, Nat Commun 2020 Oct 2;11(1):4965.
Razelle Kurzrock, MD
Distinguished Professor of Medicine
Associate Director, Clinical Science,
Director, Center for Personalized Cancer Therapy,
Director, Rare Tumor Clinic,
Leader, Experimental Therapeutics
UC San Diego - Moores Cancer Center
Sponsored by Roche